Ocean Bio-Chem OBCI
$ 12.97
0.04%
Quarterly report 2022-Q2
added 12-23-2023
Ocean Bio-Chem Balance Sheet 2011-2024 | OBCI
Annual Balance Sheet Ocean Bio-Chem
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-4.84 M | -7.39 M | -1.91 M | 3.1 M | 1.85 M | -3.74 M | -1.78 M | -1.95 M | -1.56 M | 393 K | 2.6 M |
Long Term Debt |
7.75 M | 3.65 M | 4.13 M | 4.5 M | 4.05 M | - | 260 K | 692 K | 1.11 M | 1.51 M | 1.94 M |
Long Term Debt Current |
89.6 K | 86.4 K | 83.3 K | - | - | - | - | - | - | - | 400 K |
Total Non Current Liabilities |
- | 4.29 M | 4.72 M | 4.79 M | 4.24 M | 264 K | 694 K | 951 K | 1.36 M | 1.76 M | 2.19 M |
Total Current Liabilities |
4.65 M | 3.7 M | 2.83 M | 3.01 M | 2.86 M | 2.89 M | 2.65 M | 3 M | 2.62 M | 2.82 M | 3.66 M |
Total Liabilities |
12.8 M | 7.99 M | 7.55 M | 7.8 M | 7.09 M | 3.16 M | 3.35 M | 3.95 M | 3.97 M | 4.58 M | 5.85 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
36.6 M | 29.3 M | 20.4 M | 17.4 M | 15.2 M | 13.1 M | 11.6 M | 11.1 M | 9.48 M | 8.02 M | 6.06 M |
Total Assets |
60.3 M | 47.9 M | 38.3 M | 35.2 M | 32 M | 25.7 M | 24 M | 24 M | 22.2 M | 21 M | 19.9 M |
Cash and Cash Equivalents |
12.7 M | 11.1 M | 6.13 M | 1.4 M | 2.42 M | 4.07 M | 2.47 M | 3.06 M | 3.07 M | 1.51 M | 585 K |
Book Value |
47.4 M | 39.9 M | 30.7 M | 27.4 M | 24.9 M | 22.5 M | 20.6 M | 20 M | 18.3 M | 16.4 M | 14 M |
Total Shareholders Equity |
47.4 M | 39.9 M | 30.7 M | 27.4 M | 24.9 M | 22.5 M | 20.6 M | 20 M | 18 M | 16.2 M | 13.8 M |
All numbers in USD currency
Quarterly Balance Sheet Ocean Bio-Chem
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | 7.52 M | 7.75 M | 7.98 M | 3.47 M | 3.61 M | 3.73 M | 3.73 M | 3.73 M | 3.73 M | 4.14 M | 4.14 M | 4.14 M | 4.14 M | 4.51 M | 4.51 M | 4.51 M | 4.51 M | 4.08 M | 4.08 M | 4.08 M | 4.08 M | 50.4 K | 50.4 K | 50.4 K | 50.4 K | 329 K | 329 K | 329 K | 329 K | 692 K | 692 K | 692 K | 692 K | 1.12 M | 1.12 M | 1.12 M | 1.12 M | 1.53 M | 1.53 M | 1.53 M | 1.84 M | 1.94 M | 2.04 M | 2.27 M | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | 17.4 M | 13.6 M | 12.8 M | 16.2 M | 10.4 M | 9.67 M | 7.99 M | 11.2 M | 10.6 M | 8.45 M | 7.55 M | 7.55 M | 7.55 M | 7.55 M | 7.8 M | 7.8 M | 7.8 M | 7.8 M | 7.09 M | 7.09 M | 7.09 M | 7.09 M | 3.16 M | 3.16 M | 3.16 M | 3.16 M | 3.22 M | 3.22 M | 3.35 M | 3.35 M | 3.95 M | 3.95 M | 3.95 M | 3.95 M | 4.04 M | 3.97 M | 3.97 M | 3.97 M | 4.58 M | 4.58 M | 4.58 M | 4.58 M | 5.85 M | 5.85 M | 5.85 M | 5.85 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | - | 36.8 M | 37.5 M | 36.6 M | 36.2 M | 33.2 M | 30.9 M | 29.3 M | 28.6 M | 24.1 M | 21.1 M | 20.4 M | 20.4 M | 20.4 M | 20.4 M | 17.4 M | 17.4 M | 17.4 M | 17.4 M | 15.2 M | 15.2 M | 15.2 M | 15.2 M | 13.1 M | 13.1 M | 13.1 M | 13.1 M | 11.6 M | 11.6 M | 11.6 M | 11.6 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 9.48 M | 9.48 M | 9.48 M | 9.48 M | 8.02 M | 8.02 M | 8.02 M | 8.02 M | 6.06 M | 6.06 M | 6.06 M | 6.06 M |
Total Assets |
- | - | 65.1 M | 62 M | 60.3 M | 63.1 M | 54.3 M | 51.2 M | 47.9 M | 50.1 M | 45 M | 39.8 M | 38.3 M | 38.3 M | 38.3 M | 38.3 M | 35.2 M | 35.2 M | 35.2 M | 35.2 M | 32 M | 32 M | 32 M | 32 M | 25.7 M | 25.7 M | 25.7 M | 25.7 M | 23.9 M | 23.9 M | 24 M | 24 M | 24 M | 24 M | 24 M | 24 M | 22.3 M | 22.2 M | 22.2 M | 22.2 M | 21 M | 21 M | 21 M | 21 M | 19.9 M | 19.9 M | 19.9 M | 19.9 M |
Cash and Cash Equivalents |
- | - | - | 10.2 M | 12.7 M | 10.7 M | 8.3 M | 11.2 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 6.13 M | 6.13 M | 6.13 M | 6.13 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 2.42 M | 2.42 M | 2.42 M | 2.42 M | 4.07 M | 4.07 M | 4.07 M | 4.07 M | 2.47 M | 2.47 M | 2.47 M | 2.47 M | 3.06 M | 3.06 M | 3.06 M | 3.06 M | 3.07 M | 3.07 M | 3.07 M | 3.07 M | 1.51 M | 775 K | 1.13 M | 685 K | 585 K | 585 K | 585 K | 585 K |
Book Value |
- | - | 47.7 M | 48.4 M | 47.4 M | 46.9 M | 43.9 M | 41.5 M | 39.9 M | 38.9 M | 34.5 M | 31.4 M | 30.7 M | 30.7 M | 30.7 M | 30.7 M | 27.4 M | 27.4 M | 27.4 M | 27.4 M | 24.9 M | 24.9 M | 24.9 M | 24.9 M | 22.5 M | 22.5 M | 22.5 M | 22.5 M | 20.6 M | 20.6 M | 20.6 M | 20.6 M | 20 M | 20 M | 20 M | 20 M | 18.3 M | 18.3 M | 18.3 M | 18.3 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 14 M | 14 M | 14 M | 14 M |
Total Shareholders Equity |
- | - | 47.7 M | 48.4 M | 47.4 M | 46.9 M | 43.9 M | 41.5 M | 39.9 M | 38.9 M | 34.5 M | 31.4 M | 30.7 M | 30.1 M | 30.7 M | 27.7 M | 27.4 M | 27.4 M | 27.4 M | 27.4 M | 24.9 M | 24.9 M | 24.9 M | 24.9 M | 22.5 M | 22.5 M | 22.5 M | 22.5 M | 20.6 M | 20.6 M | 20.6 M | 20.6 M | 20 M | 20 M | 20 M | 20 M | 18.3 M | 18 M | 18 M | 18 M | 16.2 M | 16.2 M | 16.2 M | 16.2 M | 13.8 M | 13.8 M | 13.8 M | 13.8 M |
All numbers in USD currency